BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 25745769)

  • 1. Influence of cyclosporin A on expression pattern of genes associated with dna repair in human dermal fibroblasts.
    Hibner G; Zajdel A; Wilczok A
    Acta Pol Pharm; 2014; 71(6):966-71. PubMed ID: 25745769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Cyclosporine A on Dermal Fibroblast Cell - Transcriptomic Analysis of Inflammatory Response Pathway.
    Janikowska G; Kurzeja E; Janikowski M; Strzałka-Mrozik B; Pyka-Pająk A; Janikowski T
    Curr Pharm Biotechnol; 2020; 21(12):1213-1223. PubMed ID: 32297577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYCLOSPORIN A AFFECTS THE PROLIFERATION PROCESS IN NORMAL HUMAN DERMAL FIBROBLASTS.
    Janikowska G; Janikowsk T; Pyka A; Wilczok A; Mazurek U
    Acta Pol Pharm; 2016; 73(1):55-63. PubMed ID: 27008801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporin A inhibits nucleotide excision repair via downregulation of the xeroderma pigmentosum group A and G proteins, which is mediated by calcineurin inhibition.
    Kuschal C; Thoms KM; Boeckmann L; Laspe P; Apel A; Schön MP; Emmert S
    Exp Dermatol; 2011 Oct; 20(10):795-9. PubMed ID: 21707758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inter-laboratory comparison of human renal proximal tubule (HK-2) transcriptome alterations due to Cyclosporine A exposure and medium exhaustion.
    Jennings P; Aydin S; Bennett J; McBride R; Weiland C; Tuite N; Gruber LN; Perco P; Gaora PO; Ellinger-Ziegelbauer H; Ahr HJ; Kooten CV; Daha MR; Prieto P; Ryan MP; Pfaller W; McMorrow T
    Toxicol In Vitro; 2009 Apr; 23(3):486-99. PubMed ID: 19159671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporin A decreases the degradation of type I collagen in rat gingival overgrowth.
    Kataoka M; Shimizu Y; Kunikiyo K; Asahara Y; Yamashita K; Ninomiya M; Morisaki I; Ohsaki Y; Kido JI; Nagata T
    J Cell Physiol; 2000 Mar; 182(3):351-8. PubMed ID: 10653601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of posttransplant squamous cell carcinoma: the potential role of cyclosporine a in carcinogenesis.
    Tiu J; Li H; Rassekh C; van der Sloot P; Kovach R; Zhang P
    Laryngoscope; 2006 May; 116(5):762-9. PubMed ID: 16652084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin A, but not everolimus, inhibits DNA repair mediated by calcineurin: implications for tumorigenesis under immunosuppression.
    Thoms KM; Kuschal C; Oetjen E; Mori T; Kobayashi N; Laspe P; Boeckmann L; Schön MP; Emmert S
    Exp Dermatol; 2011 Mar; 20(3):232-6. PubMed ID: 21323745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cyclosporin A on human gingival fibroblast collagen turnover in relation to the development of gingival overgrowth: an in vitro study.
    Gagliano N; Moscheni C; Dellavia C; Torri C; Stabellini G; Ferrario VF; Gioia M
    Biomed Pharmacother; 2004 May; 58(4):231-8. PubMed ID: 15183848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A preliminary examination of the role of NFAT 3 in human skin, cultured keratocytes and dermal fibroblasts.
    Al-Daraji WI; Tugrul S; Dempsey E; Zelger B; Abdellaoui A; Prescott R; Zelger B
    J Cutan Pathol; 2010 Sep; 37(9):e21-36. PubMed ID: 20653821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients.
    Herman M; Weinstein T; Korzets A; Chagnac A; Ori Y; Zevin D; Malachi T; Gafter U
    J Lab Clin Med; 2001 Jan; 137(1):14-20. PubMed ID: 11150019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-oxidative and anti-aging activities of 2-O-α-glucopyranosyl-L-ascorbic acid on human dermal fibroblasts.
    Taniguchi M; Arai N; Kohno K; Ushio S; Fukuda S
    Eur J Pharmacol; 2012 Jan; 674(2-3):126-31. PubMed ID: 22119379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin A induces proliferation in human gingival fibroblasts via induction of transforming growth factor-beta1.
    Cotrim P; Martelli-Junior H; Graner E; Sauk JJ; Coletta RD
    J Periodontol; 2003 Nov; 74(11):1625-33. PubMed ID: 14682659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of telomerase activity in gingival fibroblasts of cyclosporine-treated patients.
    Biray C; Nizam N; Gunduz C; Sonmez S; Cavdar C; Saglam F; Atilla K; Camsari T
    Transplant Proc; 2008; 40(1):184-5. PubMed ID: 18261581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cyclosporin A-induced gingival overgrowth by azithromycin through phagocytosis: an in vivo and in vitro study.
    Paik JW; Kim CS; Cho KS; Chai JK; Kim CK; Choi SH
    J Periodontol; 2004 Mar; 75(3):380-7. PubMed ID: 15088875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 levels in gingival fibroblasts of cyclosporin A-treated patients.
    Tüter G; Serdar MA; Yalim M; Gürhan IS; Baloş K
    J Periodontol; 2002 Nov; 73(11):1273-8. PubMed ID: 12479630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic monitoring of immunosuppressive effects indicates reduced cyclosporine activity during telaprevir therapy.
    Roos K; Gotthardt D; Giese T; Schnitzler P; Stremmel W; Czock D; Eisenbach C
    Liver Transpl; 2014 Sep; 20(9):1106-17. PubMed ID: 24890314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus fails to regulate collagen expression in dermal fibroblasts.
    Wong VW; You F; Januszyk M; Kuang AA
    J Surg Res; 2013 Sep; 184(1):678-90. PubMed ID: 23647800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of type I plasminogen activator inhibitor in human gingival fibroblasts with cyclosporine A.
    Ho YC; Lin HJ; Tsai CH; Chang YC
    Oral Dis; 2010 May; 16(4):396-401. PubMed ID: 20233320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effect of Cyclosporin A and FK506 on SPARC mRNA expression by human gingival fibroblasts.
    Gagliano N; Moscheni C; Torri C; Dellavia C; Stabellini G; Ferrario VF; Gioia M
    Biomed Pharmacother; 2005 Jun; 59(5):249-52. PubMed ID: 15890490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.